BioMarin Pharmaceutical Inc. (BMRN)
BMRN price $55.17 -1.27 -2.25%
- Ticker
- BMRN
- Price
- $55.17
- Change
- -1.27 -2.25%
- Market cap
- $10.68B
- P/E
- 148.53
- Forward P/E
- 11.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 51
BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage disorder, and Naglazyme…